Salu Medical

Salu Medical (赛陆医疗) is a Shenzhen-based life sciences tools company developing domestic sequencing platforms. ZhenFund led its angel round and has featured it repeatedly in portfolio updates: the firm was named a national-level "little giant" enterprise by China's Ministry of Industry and Information Technology as of late 2024 , and completed an A+ round in mid-2025 to fund registration of its all-domestic sequencing platform, capacity expansion, and global market push . That same year it showcased high-throughput sequencing technology and multi-omics solutions at ESHG 2025 in Milan . The company's Salus Pro platform had already obtained regulatory certification prior to the A+ round .